Evaluation of the Carbapenem Inactivation Method for Detection of Carbapenemase-Producing Gram-Negative Bacteria in Comparison with the RAPIDEC CARBA NP

Microbial Drug Resistance

Volumn 23, Issue 4, 2017, Pages 457-461

  Aktaş, Elif ^a   Malkoçoǧlu, Gülşah ^b   Otlu, Barlş ^c   Çiçek, Ayşegül Çopur ^d   Külah, Canan ^e   Cömert, Füsun ^e   Sandalll, Cemal ^d   Gürsoy, Nafia Canan ^c   Erdemir, Duygu ^a   Bulut, Mehmet Emin ^a  

^a II Ear Nose Throat Head and Neck Surgery   (Turkey)

^b Kocaeli   (Turkey)

^c INONU UNIVERSITY   (Turkey)

^d RECEP TAYYIP ERDOGAN UNIVERSITY   (Turkey)

^e ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

CARBA NP; carbapenemase; CIM

Indexed keywords

BACTERIAL ENZYME; CARBAPENEMASE; MEROPENEM; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; THIENAMYCIN DERIVATIVE;

ACINETOBACTER BAUMANNII; ANALYTICAL EQUIPMENT; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; CARBAPENEM INACTIVATION METHOD; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CONTROLLED STUDY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RAPIDEC CARBA NP TEST; SENSITIVITY AND SPECIFICITY; COMPARATIVE STUDY; DIAGNOSTIC KIT; DRUG EFFECTS; DRUG INACTIVATION; ENTEROBACTERIACEAE; ENZYMOLOGY; GENE EXPRESSION; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; STANDARDS;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; ENTEROBACTERIACEAE; GENE EXPRESSION; INACTIVATION, METABOLIC; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; THIENAMYCINS;

EID: 85020193946     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2016.0092     Document Type: Article

References (15)

1. Livermore, D.M. 2001. Of Pseudomonas, porins, pumps and carbapenems. J. Antimicrob. Chemother. 47:247-250.
2. Jacoby, G.A., D.M. Mills, and N. Chow. 2004. Role of beta-lactamases and porins in resistance to ertapenem and other beta-lactams in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48:3203-3206.
3. Martinez-Martinez, L. 2008. Extended-spectrum b-lactamases and the permeability barrier. Clin. Microbiol. Infect. 14:82-89.
4. Nordmann, P., L. Poirel, and L. Dortet. 2012. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis. 18:1503-1507.
5. Dortet, L., L. Poirel, and P. Nordmann. 2012. Rapid detection of carbapenemase-producing Pseudomonas spp. J. Clin. Microbiol. 50:3773-3776.
6. Vasoo, S., S.A. Cunningham, P.C. Kohner, P.J. Simner, J.N. Mandrekar, K. Lolans, M.K. Hayden, and R. Patel. 2013. Comparison of a novel, rapid chromogenic biochemical assay, the Carba NP test, with the modified Hodge test for detection of carbapenemase-producing gram-negative bacilli. J. Clin. Microbiol. 51:3097-3101.
7. Clinical and Laboratory Standards Institute. 2015. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Fifth Informational Supplement M100-S25. CLSI, Wayne, PA.
8. The European Committee on Antimicrobial Susceptibility Testing. EUCAST Guidelines for Detection of Resistance Mechanisms and Specific Resistances of Clinical and/or Epidemiological Importance. December 2013 (Version 1.0). Available at www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files/Resistance-mechanisms/EUCAST-detection- of-resistance-mechanisms-v1.0-20131211.pdf, accessed January 26, 2016 (Online).
9. van der Zwaluw, K., A.deHaan, G.N. Pluister, H.J. Bootsma, A.J. de Neeling, and L.M. Schouls. 2015. The carbapenem inactivation method (CIM), asimple and low-cost alternative for the Carba NP test to assess phenotypic carbapenemase activity in gram-negative rods. PLoS One 10:e0123690.
10. Tijet, N., S.N. Patel, and R.G. Melano. 2016. Detection of carbapenemase activity in Enterobacteriaceae: comparison of the carbapenem inactivation method versus the Carba NP test. J. Antimicrob. Chemother. 71:274-276.
11. Cicek, A.C., A. Saral, M. Iraz, A. Ceylan, A.O. Duzgun, A.Y. Peleg, and C. Sandalli. 2014. OXA-and GES-type b-lactamases predominate in extensively drug-resistant Acinetobacter baumannii isolates from a Turkish University Hospital. Clin. Microbiol. Infect. 20:410-415.
12. Kulah, C., M.J. Mooij, F. Comert, E. Aktas, G. Celebi, N. Ozlu, M.C. Rijnsburger, and P.H. Savelkoul. 2010. Characterisation of carbapenem-resistant Acinetobacter bau-mannii outbreak strains producing OXA-58 in Turkey. Int. J. Antimicrob. Agents 36:114-118.
13. Malkoçoglu, G., E. Aktaxs, B. Bayraktar, B. Otlu, and M.E. Bulut. 2016. VIM-1, VIM-2, and GES-5 carbapenemases among Pseudomonas aeruginosa isolates at a Tertiary Hospital in Istanbul, Turkey. Microb. Drug Resist. [Epub ahead of print]; DOI: 10.1089/mdr.2016.0012.
14. Tijet, N., D. Boyd, S.N. Patel, M.R. Mulvey, and R.G. Melano. 2013. Evaluation of the Carba NP test for rapid detection of carbapenemase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob. Agents Che-mother. 57:4578-4580.
15. Osterblad, M., A.J. Hakanen, and J. Jalava. 2014. Evaluation of the Carba NP test for carbapenemase detection. Antimicrob. Agents Chemother. 58:7553-7556.